Prostate cancer is the commonest male cancer with over 5 million survivors in US alone.ย Worldwide, the problem is staggering and has attracted significant attention by media, scientists and cancer experts.ย ย Significant research, discoveries, innovations and advances in treatment of this cancer ha
Prostate Cancer: A Comprehensive Perspective || Androgen and Androgen Receptor-Directed Therapy as Initial Treatment for Prostate Cancer
โ Scribed by Tewari, Ashutosh
- Book ID
- 120405469
- Publisher
- Springer London
- Year
- 2012
- Tongue
- English
- Weight
- 532 KB
- Edition
- 2013
- Category
- Article
- ISBN
- 1447128648
No coin nor oath required. For personal study only.
โฆ Synopsis
Prostate cancer is the commonest male cancer with over 5 million survivors in US alone.ย Worldwide, the problem is staggering and has attracted significant attention by media, scientists and cancer experts.ย ย Significant research, discoveries, innovations and advances in treatment of this cancer have produced voluminous literature which is difficult to synthesize and assimilate by the medical community. Prostate Cancer: A Comprehensive Perspective is a comprehensive and definitive source which neatly resolves this problem. It covers relevant literature by leading experts in basic science, molecular biology, epidemiology, cancer prevention, cellular imaging, staging, treatment, targeted therapeutics and innovative technologies. ย Prostate Cancer: A Comprehensive Perspective, is a valuable and timely resource for urologists and oncologists.
๐ SIMILAR VOLUMES
Prostate cancer is the commonest male cancer with over 5 million survivors in US alone.ย Worldwide, the problem is staggering and has attracted significant attention by media, scientists and cancer experts.ย ย Significant research, discoveries, innovations and advances in treatment of this cancer ha
## Abstract Androgen deprivation has been the standard therapy for advanced and metastatic prostate cancer for over half a century, as prostate tumors are initially dependent on androgens for growth and survival. Unfortunately, in most patients undergoing androgen ablation, relapse (recurrent tumor